REQUEST A DEMO
Total
USD $0.00
Search more companies

Vesalius Pharma S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Vesalius Pharma S.A.S Profile Updated: May 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Vesalius Pharma S.A.S is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on October 01, 1999. 36 (2026) employees currently work for Vesalius Pharma S.A.S. There was a net sales revenue drop of 99.91% reported in Vesalius Pharma S.A.S’s latest financial highlights for 2025. A growth of 6.98% was recorded in its total assets. In, 2025, the company’s net profit margin increased by 6666.78%.

Headquarters
Cra 21 No 169 - 76
Bogota D.C.; Bogota D.C; Postal Code: 1024

Contact Details: Purchase the Vesalius Pharma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Vesalius Pharma S.A.S report to view the information.
Registered Capital:
Purchase the Vesalius Pharma S.A.S report to view the information.
Financial Auditors:
Purchase the Vesalius Pharma S.A.S report to view the information.
Incorporation Date:
October 01, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
17%
Purchase this report to view the information.
17%
Company Performance
Financial values in the chart are available after Vesalius Pharma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-99.91%
Total Operating Revenue
-99.91%
Operating Profit
-62.72%
Net Profit/Loss for the Period
-21.34%
Total Assets
6.98%
Total Equity
5.16%
Operating Profit Margin
10333.51%
Net Profit Margin
6666.78%
Return on Equity (ROE)
-1.53%
Quick Ratio
4.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?